Skip to content

Microwave Ablation for Leiomyoma

Prospective Observational Trial of Microwave Ablation for Leiomyoma (MYOMIC2)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04240262
Acronym
MYOMIC2
Enrollment
200
Registered
2020-01-27
Start date
2020-01-20
Completion date
2024-07-31
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine Fibroid

Brief summary

This prospective observational study aims to evaluate the effectiveness and acceptability of percutaneous or vaginal ultrasound guided microwave ablation for the treatment of symptoms related to uterine fibroids. We will include 200 women.

Interventions

None listed

Sponsors

Karolinska Institutet
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
25 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* premenopausal * no future child wish * acceptable risks for general anestesia or sedation * willing to comply with protocol

Exclusion criteria

* current or future child wish * bleeding disorder with increased risk of bleeding

Design outcomes

Primary

MeasureTime frameDescription
Symptom severity of uterine fibroids6 months post treatmentScore of validated form Uterine Fibroid symptom- Quality of Life questionnaire. minumum 0, maximum 100 where higher scores indicate higher symptom severity

Secondary

MeasureTime frameDescription
acceptability2 hours post treatment and 6 months post treatment (+/- 2 weeks)Answer to question: if you were to recommend the treatment to a friend on a scale from 1-7 where 7 is the highest rating- what would you say.
Quality of Life score6 months post treatmentScore of validated form Uterine Fibroid symptom- Quality of Life questionnaire.minumum 0, maximum 100 where higher scores indicate higher quality of life
menstrual bleeding6 months post treatmentScore on validated Pictorial Bleeding assessment chart. minimum 1, no maximum. higher scores indicate more bleeding.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026